CN1110485C - 1－芳基磺酰基、芳基(硫代)羰基－哒嗪子基衍生物及其制法 - Google Patents

1－芳基磺酰基、芳基(硫代)羰基－哒嗪子基衍生物及其制法 Download PDF

Info

Publication number: CN1110485C
Authority: CN; China
Prior art keywords: hydrogen; diaza; compound; dichloro; benzo
Prior art date: 1995-11-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CN96199481A

Other languages

English (en)

Chinese (zh)

Other versions

CN1207091A (zh

Inventor

D·W·库姆斯

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ortho Pharmaceutical Corp

Original Assignee

Ortho Pharmaceutical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-06

Filing date

1996-10-10

Publication date

2003-06-04

1996-10-10 Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp

1999-02-03 Publication of CN1207091A publication Critical patent/CN1207091A/zh

2003-06-04 Application granted granted Critical

2003-06-04 Publication of CN1110485C publication Critical patent/CN1110485C/zh

2016-10-10 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/36—Benzo-cinnolines

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Pregnancy & Childbirth (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

CN96199481A 1995-11-06 1996-10-10 1－芳基磺酰基、芳基(硫代)羰基－哒嗪子基衍生物及其制法 Expired - Fee Related CN1110485C (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US790095P	1995-11-06	1995-11-06
US60/007,900		1995-11-06

Publications (2)

Publication Number	Publication Date
CN1207091A CN1207091A (zh)	1999-02-03
CN1110485C true CN1110485C (zh)	2003-06-04

Family

ID=21728709

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN96199481A Expired - Fee Related CN1110485C (zh)	1995-11-06	1996-10-10	1－芳基磺酰基、芳基(硫代)羰基－哒嗪子基衍生物及其制法

Country Status (17)

Country	Link
JP (1)	JP2000501073A (ru)
KR (1)	KR100360614B1 (ru)
CN (1)	CN1110485C (ru)
AU (1)	AU704507B2 (ru)
BR (1)	BR9611407A (ru)
CZ (1)	CZ286789B6 (ru)
HU (1)	HU225162B1 (ru)
IL (1)	IL124320A (ru)
MX (1)	MX9803605A (ru)
NO (1)	NO310460B1 (ru)
NZ (1)	NZ319979A (ru)
PL (1)	PL185618B1 (ru)
RU (1)	RU2175969C2 (ru)
TW (1)	TW460467B (ru)
UA (1)	UA48989C2 (ru)
WO (1)	WO1997017332A1 (ru)
ZA (1)	ZA969298B (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816467A (en) *	1987-01-09	1989-03-28	Farmitalia Carlo Erba S.R.L	Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use
WO1989004306A1 (fr) *	1987-11-02	1989-05-18	Yoshitomi Pharmaceutical Industries, Ltd.	Composes de pyridazine fusionnes et leurs utilisations medicales
WO1993004069A1 (fr) *	1991-08-27	1993-03-04	Yoshitomi Pharmaceutical Industries, Ltd.	Compose de pyridazine lie par fusion et utilisation pharmaceutique d'un tel compose

1996
- 1996-10-10 NZ NZ319979A patent/NZ319979A/xx unknown
- 1996-10-10 JP JP9518177A patent/JP2000501073A/ja not_active Ceased
- 1996-10-10 PL PL96326669A patent/PL185618B1/pl not_active IP Right Cessation
- 1996-10-10 IL IL12432096A patent/IL124320A/en not_active IP Right Cessation
- 1996-10-10 WO PCT/US1996/016227 patent/WO1997017332A1/en not_active Ceased
- 1996-10-10 UA UA98052267A patent/UA48989C2/ru unknown
- 1996-10-10 RU RU98110813/04A patent/RU2175969C2/ru not_active IP Right Cessation
- 1996-10-10 AU AU72637/96A patent/AU704507B2/en not_active Ceased
- 1996-10-10 CZ CZ19981380A patent/CZ286789B6/cs not_active IP Right Cessation
- 1996-10-10 CN CN96199481A patent/CN1110485C/zh not_active Expired - Fee Related
- 1996-10-10 BR BR9611407-0A patent/BR9611407A/pt not_active Application Discontinuation
- 1996-10-10 KR KR10-1998-0703345A patent/KR100360614B1/ko not_active Expired - Fee Related
- 1996-10-10 HU HU0201305A patent/HU225162B1/hu not_active IP Right Cessation
- 1996-11-05 ZA ZA9609298A patent/ZA969298B/xx unknown
- 1996-11-25 TW TW085114479A patent/TW460467B/zh not_active IP Right Cessation
1998
- 1998-05-05 NO NO19982030A patent/NO310460B1/no unknown
- 1998-05-06 MX MX9803605A patent/MX9803605A/es not_active IP Right Cessation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.MED.CHEM.VOL14,NO3 1971-01-01 H.HOLAVAJR.ETAL *

Also Published As

Publication number	Publication date
PL326669A1 (en)	1998-10-12
HUP0201305A3 (en)	2003-02-28
NO310460B1 (no)	2001-07-09
CZ286789B6 (en)	2000-07-12
BR9611407A (pt)	1999-12-28
CN1207091A (zh)	1999-02-03
IL124320A0 (en)	1998-12-06
TW460467B (en)	2001-10-21
UA48989C2 (ru)	2002-09-16
ZA969298B (en)	1998-05-05
AU7263796A (en)	1997-05-29
HUP0201305A2 (hu)	2002-12-28
KR19990067340A (ko)	1999-08-16
CZ138098A3 (cs)	1998-09-16
IL124320A (en)	2001-10-31
RU2175969C2 (ru)	2001-11-20
NO982030D0 (no)	1998-05-05
KR100360614B1 (ko)	2003-06-02
PL185618B1 (pl)	2003-06-30
NO982030L (no)	1998-06-23
AU704507B2 (en)	1999-04-22
HU225162B1 (en)	2006-07-28
MX9803605A (es)	1998-09-30
JP2000501073A (ja)	2000-02-02
WO1997017332A1 (en)	1997-05-15
NZ319979A (en)	1999-11-29

Publication	Publication Date	Title
CN1187367C (zh)	2005-02-02	具有麻醉剂活性的3α－羟基－3β－甲氧基甲基－21－杂环取代的类固醇
CN1105708C (zh)	2003-04-16	1－苯基吡唑化合物类及其药学应用
CN1155589C (zh)	2004-06-30	调节雌激素受体的化合物
CN1102596C (zh)	2003-03-05	5H－噻唑并[3,2－a]嘧啶衍生物
CN1131666A (zh)	1996-09-25	三环吡唑衍生物
JPH08109169A (ja)	1996-04-30	非ペプチドタキキニン受容体拮抗物質
WO1999040913A1 (en)	1999-08-19	Chemical compounds
FR2927625A1 (fr)	2009-08-21	Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
CN1429223A (zh)	2003-07-09	新颖苯并呋喃衍生物
CN1166623C (zh)	2004-09-15	2-苯氧基苯胺类衍生物
CN1110485C (zh)	2003-06-04	1－芳基磺酰基、芳基(硫代)羰基－哒嗪子基衍生物及其制法
AU780992B2 (en)	2005-04-28	Indole derivatives as MCP-1 receptor antagonists
US5753655A (en)	1998-05-19	1-arylsulphonyl, arylcarbonyl and arylthiocarbonyl pyridazino derivatives and methods of preparation
CN100336813C (zh)	2007-09-12	作为mGluR1增强剂的唑
CN1230948A (zh)	1999-10-06	吡喃并吲哚和咔唑cox－2抑制剂
CN1395564A (zh)	2003-02-05	作为mcp－1受体拮抗剂的吲哚类衍生物
CN1375490A (zh)	2002-10-23	新的茚并吲哚酮化合物,其制备方法和含有这种化合物的药物组合物
CA2215178A1 (en)	1997-01-16	4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists
CN1264365A (zh)	2000-08-23	3－苯甲酰基吲哚衍生物及含有它们的药物
JP2003073374A (ja)	2003-03-12	２環性芳香族アミン誘導体
CN1209359C (zh)	2005-07-06	新颖的二氢吲哚化合物、它们的制备方法和含有它们的药物组合物
CN1656099A (zh)	2005-08-17	3－杂芳基－3,5－二氢－4－氧代－4H－哒嗪并[4,5－b]吲哚－1－乙酰胺衍生物,其制备和在治疗中的应用
CA2236896C (en)	2006-08-15	1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation
CN1463968A (zh)	2003-12-31	2－芳基－3－取代吲哚乙酰胺类衍生物,及其医药用途
HK1075893B (en)	2008-08-08	Compounds and methods for modulation of estrogen receptors

Legal Events

Date	Code	Title
1999-02-03	C06	Publication
1999-02-03	PB01	Publication
1999-02-17	C10	Entry into substantive examination
1999-02-17	SE01	Entry into force of request for substantive examination
2003-06-04	C14	Grant of patent or utility model
2003-06-04	GR01	Patent grant
2008-12-10	C19	Lapse of patent right due to non-payment of the annual fee
2008-12-10	CF01	Termination of patent right due to non-payment of annual fee